Source: Cancer Immunity. Unidade: FMRP
Subjects: MIELOMA MÚLTIPLO, PROGNÓSTICO, NEOPLASIAS TESTICULARES
ABNT
ANDRADE, Valéria Cristina da Costa et al. Prognostic impact of cancer: testis antigen expression in advanced stage multiple myeloma patients. Cancer Immunity, v. 8, p. on-line, 2008Tradução . . Acesso em: 08 out. 2024.APA
Andrade, V. C. da C., Vettore, A. L., Felix, R. S., Almeida, M. S. S., Carvalho, F. de, Oliveira, J. S. R. de, et al. (2008). Prognostic impact of cancer: testis antigen expression in advanced stage multiple myeloma patients. Cancer Immunity, 8, on-line.NLM
Andrade VC da C, Vettore AL, Felix RS, Almeida MSS, Carvalho F de, Oliveira JSR de, Chauffaille M de LLF, Andriolo A, Caballero OL, Zago MA, Colleoni GWB. Prognostic impact of cancer: testis antigen expression in advanced stage multiple myeloma patients. Cancer Immunity. 2008 ; 8 on-line.[citado 2024 out. 08 ]Vancouver
Andrade VC da C, Vettore AL, Felix RS, Almeida MSS, Carvalho F de, Oliveira JSR de, Chauffaille M de LLF, Andriolo A, Caballero OL, Zago MA, Colleoni GWB. Prognostic impact of cancer: testis antigen expression in advanced stage multiple myeloma patients. Cancer Immunity. 2008 ; 8 on-line.[citado 2024 out. 08 ]